- Home
- MREO vs NEWT Comparison
MREO vs NEWT Comparison
Compare MREO & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- NEWT
- Stock Information
- Founded
- MREO 2015
- NEWT 1998
- Country
- MREO United Kingdom
- NEWT United States
- Employees
- MREO N/A
- NEWT N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- NEWT Major Banks
- Sector
- MREO Health Care
- NEWT Finance
- Exchange
- MREO Nasdaq
- NEWT Nasdaq
- Market Cap
- MREO 424.5M
- NEWT 335.7M
- IPO Year
- MREO N/A
- NEWT N/A
- Fundamental
- Price
- MREO $2.41
- NEWT $10.38
- Analyst Decision
- MREO Strong Buy
- NEWT Hold
- Analyst Count
- MREO 7
- NEWT 4
- Target Price
- MREO $7.71
- NEWT $14.00
- AVG Volume (30 Days)
- MREO 1.5M
- NEWT 321.0K
- Earning Date
- MREO 05-19-2025
- NEWT 05-06-2025
- Dividend Yield
- MREO N/A
- NEWT 7.32%
- EPS Growth
- MREO N/A
- NEWT 27.59
- EPS
- MREO N/A
- NEWT 1.92
- Revenue
- MREO N/A
- NEWT $352,584,000.00
- Revenue This Year
- MREO N/A
- NEWT N/A
- Revenue Next Year
- MREO $56.11
- NEWT $15.38
- P/E Ratio
- MREO N/A
- NEWT $5.39
- Revenue Growth
- MREO N/A
- NEWT 23.06
- 52 Week Low
- MREO $1.58
- NEWT $9.12
- 52 Week High
- MREO $5.02
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- MREO 50.36
- NEWT 46.89
- Support Level
- MREO $2.28
- NEWT $9.62
- Resistance Level
- MREO $2.75
- NEWT $10.26
- Average True Range (ATR)
- MREO 0.16
- NEWT 0.43
- MACD
- MREO -0.00
- NEWT 0.04
- Stochastic Oscillator
- MREO 27.66
- NEWT 55.77
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions, It has developed a financial and technology-based business model that enables itself to acquire and process its clients in a very cost-effective manner. This capability is supported in large part by NewTracker, its patented prospect management technology software, that will allow NewtekOne clients to easily interact with NewtekOne subject matter experts in the areas of Banking, Lending, Payments, Technology, Payroll, and Insurance. It offers NewtekOne's clients a single online dashboard to access all of NewtekOne's business and financial solutions. It has four reportable segments Banking, Technology, NSBF, and Payments.